Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2006-05-22 14:17:51 UTC |
---|
Update Date | 2023-02-21 17:16:23 UTC |
---|
HMDB ID | HMDB0002393 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | N-Methyl-D-aspartic acid |
---|
Description | N-Methyl-D-aspartic acid is an amino acid derivative acting as a specific agonist at the NMDA receptor, and therefore mimics the action of the neurotransmitter glutamate on that receptor. In contrast to glutamate, NMDA binds to and regulates the above receptor only, but not other glutamate receptors. NMDA is a water-soluble endogenous metabolite that plays an important role in the neuroendocrine system of species across Animalia (PMID:18096065 ). It was first synthesized in the 1960s (PMID:14056452 ). NMDA is an excitotoxin; this trait has applications in behavioural neuroscience research. The body of work utilizing this technique falls under the term "lesion studies." Researchers apply NMDA to specific regions of an (animal) subject's brain or spinal cord and subsequently test for the behaviour of interest, such as operant behaviour. If the behaviour is compromised, it suggests that the destroyed tissue was part of a brain region that made an important contribution to the normal expression of that behaviour. Examples of antagonists of the NMDA receptor are ketamine, amantadine, dextromethorphan (DXM), riluzole, and memantine. They are commonly referred to as NMDA receptor antagonists (PMID:28877137 ). |
---|
Structure | InChI=1S/C5H9NO4/c1-6-3(5(9)10)2-4(7)8/h3,6H,2H2,1H3,(H,7,8)(H,9,10)/t3-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(R)-2-Methylamino-succinic acid | ChEBI | 2-Methylamino-succinic acid | ChEBI | Methyl aspartic acid | ChEBI | N-Methyl aspartic acid | ChEBI | N-Methyl-D-aspartate | ChEBI | N-Methylaspartate | ChEBI | NMDA | ChEBI | (R)-2-Methylamino-succinate | Generator | 2-Methylamino-succinate | Generator | Methyl aspartate | Generator | N-Methyl aspartate | Generator | N-Methylaspartic acid | Generator | Acid, N-methyl-D-aspartic | MeSH | N Methyl D aspartate | MeSH | N Methyl D aspartic acid | MeSH | N Methylaspartate | MeSH | N-Me-D-asp-OH | HMDB | N-Methyl D-aspartate | HMDB | N-Methyl D-aspartic acid | HMDB |
|
---|
Chemical Formula | C5H9NO4 |
---|
Average Molecular Weight | 147.1293 |
---|
Monoisotopic Molecular Weight | 147.053157781 |
---|
IUPAC Name | (2R)-2-(methylamino)butanedioic acid |
---|
Traditional Name | N methyl D aspartate |
---|
CAS Registry Number | 6384-92-5 |
---|
SMILES | CN[C@H](CC(O)=O)C(O)=O |
---|
InChI Identifier | InChI=1S/C5H9NO4/c1-6-3(5(9)10)2-4(7)8/h3,6H,2H2,1H3,(H,7,8)(H,9,10)/t3-/m1/s1 |
---|
InChI Key | HOKKHZGPKSLGJE-GSVOUGTGSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aspartic acid and derivatives. Aspartic acid and derivatives are compounds containing an aspartic acid or a derivative thereof resulting from reaction of aspartic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Aspartic acid and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Aspartic acid or derivatives
- Alpha-amino acid
- D-alpha-amino acid
- Dicarboxylic acid or derivatives
- Fatty acid
- Amino acid
- Carboxylic acid
- Secondary aliphatic amine
- Secondary amine
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-Methyl-D-aspartic acid,1TMS,isomer #1 | CN[C@H](CC(=O)O[Si](C)(C)C)C(=O)O | 1394.6 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,1TMS,isomer #2 | CN[C@H](CC(=O)O)C(=O)O[Si](C)(C)C | 1361.2 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,1TMS,isomer #3 | CN([C@H](CC(=O)O)C(=O)O)[Si](C)(C)C | 1496.2 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,2TMS,isomer #1 | CN[C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1433.5 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,2TMS,isomer #2 | CN([C@H](CC(=O)O[Si](C)(C)C)C(=O)O)[Si](C)(C)C | 1522.1 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,2TMS,isomer #3 | CN([C@H](CC(=O)O)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1524.5 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,3TMS,isomer #1 | CN([C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1557.7 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,3TMS,isomer #1 | CN([C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1556.9 | Standard non polar | 33892256 | N-Methyl-D-aspartic acid,3TMS,isomer #1 | CN([C@H](CC(=O)O[Si](C)(C)C)C(=O)O[Si](C)(C)C)[Si](C)(C)C | 1666.6 | Standard polar | 33892256 | N-Methyl-D-aspartic acid,1TBDMS,isomer #1 | CN[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O | 1633.4 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,1TBDMS,isomer #2 | CN[C@H](CC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C | 1593.6 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,1TBDMS,isomer #3 | CN([C@H](CC(=O)O)C(=O)O)[Si](C)(C)C(C)(C)C | 1743.3 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,2TBDMS,isomer #1 | CN[C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1865.3 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,2TBDMS,isomer #2 | CN([C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O)[Si](C)(C)C(C)(C)C | 1995.7 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,2TBDMS,isomer #3 | CN([C@H](CC(=O)O)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1989.5 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,3TBDMS,isomer #1 | CN([C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2217.0 | Semi standard non polar | 33892256 | N-Methyl-D-aspartic acid,3TBDMS,isomer #1 | CN([C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2202.2 | Standard non polar | 33892256 | N-Methyl-D-aspartic acid,3TBDMS,isomer #1 | CN([C@H](CC(=O)O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2093.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-Methyl-D-aspartic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0k96-9300000000-416b6ee56e62fb8e5961 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Methyl-D-aspartic acid GC-MS (2 TMS) - 70eV, Positive | splash10-00dl-9410000000-4a49e66d4a20edeb3235 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Methyl-D-aspartic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Methyl-D-aspartic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-9600000000-7a4c870f26f91384c5d0 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-000f-9000000000-5a5c118fa9bc800c8c72 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0006-9000000000-b494ed61acdeddeb3be4 | 2012-07-25 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 0V, Positive-QTOF | splash10-0002-1900000000-87587cfe05ee404f1550 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 35V, Negative-QTOF | splash10-0gba-1900000000-849defcb6a9a98faef16 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Negative-QTOF | splash10-0gba-1900000000-9f82f9c552f606136a19 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 30V, Positive-QTOF | splash10-0006-9000000000-b6e45215a0b6b9a0960f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 0V, Positive-QTOF | splash10-0007-9500000000-060344e1da8123dc5c51 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 40V, Positive-QTOF | splash10-0006-9000000000-bbf199eb1c5bbac7de35 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Positive-QTOF | splash10-000i-9300000000-9f1996c5b204a0ee904e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Positive-QTOF | splash10-000f-9000000000-18a491a74a3279ec33d1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 20V, Positive-QTOF | splash10-000l-9000000000-b9b082c40ee1ed6fbb8b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Positive-QTOF | splash10-000i-9300000000-435580f32c2f9263f08f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 20V, Positive-QTOF | splash10-000f-9000000000-d6cd5876d7888f53004a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Positive-QTOF | splash10-000i-9400000000-6e3a2b4573d59f5f903d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 40V, Positive-QTOF | splash10-0006-9000000000-69cb5c680dcf502b4d39 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 20V, Positive-QTOF | splash10-000l-9000000000-3b16cb5a635969b81fb4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 40V, Positive-QTOF | splash10-0006-9000000000-6e09556b565532cc28ce | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 35V, Positive-QTOF | splash10-000i-9600000000-f385ad30a0df8435d853 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Positive-QTOF | splash10-001i-0900000000-eeb3a907ee733c1543e9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 20V, Positive-QTOF | splash10-0f80-9600000000-1c3def640e73db97c7e4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 40V, Positive-QTOF | splash10-0a4i-9000000000-9f7de36da4128db64ccb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 10V, Negative-QTOF | splash10-0f6t-0900000000-6c4446f90caead6f5b51 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 20V, Negative-QTOF | splash10-0ufs-3900000000-44106308c45837087fe5 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Methyl-D-aspartic acid 40V, Negative-QTOF | splash10-0ac3-9100000000-fe891bbc2ab7063b8bac | 2017-09-01 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Baskys A, Fang L, Bayazitov I: Activation of neuroprotective pathways by metabotropic group I glutamate receptors: a potential target for drug discovery? Ann N Y Acad Sci. 2005 Aug;1053:55-73. [PubMed:16179509 ]
- Hitchcock IS, Skerry TM, Howard MR, Genever PG: NMDA receptor-mediated regulation of human megakaryocytopoiesis. Blood. 2003 Aug 15;102(4):1254-9. Epub 2003 Mar 20. [PubMed:12649130 ]
- Miller RF: D-Serine as a glial modulator of nerve cells. Glia. 2004 Aug 15;47(3):275-83. [PubMed:15252817 ]
- Sanelli TR, Sopper MM, Strong MJ: Sequestration of nNOS in neurofilamentous aggregate bearing neurons in vitro leads to enhanced NMDA-mediated calcium influx. Brain Res. 2004 Apr 9;1004(1-2):8-17. [PubMed:15033415 ]
- Weyermann J, Lochmann D, Georgens C, Zimmer A: Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. Eur J Pharm Biopharm. 2005 Apr;59(3):431-8. [PubMed:15760723 ]
- Baskys A, Blaabjerg M: Understanding regulation of nerve cell death by mGluRs as a method for development of successful neuroprotective strategies. J Neurol Sci. 2005 Mar 15;229-230:201-9. Epub 2004 Dec 15. [PubMed:15760640 ]
- Hardingham GE, Bading H: The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 2003 Feb;26(2):81-9. [PubMed:12536131 ]
- Lareo LR, Corredor C: Ionotropic glutamate receptor activated by N-methyl-D-aspartate: a key molecule of conscious life. Med Hypotheses. 2004;63(2):245-9. [PubMed:15236783 ]
- Fonnum F, Lock EA: The contributions of excitotoxicity, glutathione depletion and DNA repair in chemically induced injury to neurones: exemplified with toxic effects on cerebellar granule cells. J Neurochem. 2004 Feb;88(3):513-31. [PubMed:14720201 ]
- Wang GS, Hong CJ, Yen TY, Huang HY, Ou Y, Huang TN, Jung WG, Kuo TY, Sheng M, Wang TF, Hsueh YP: Transcriptional modification by a CASK-interacting nucleosome assembly protein. Neuron. 2004 Apr 8;42(1):113-28. [PubMed:15066269 ]
- Liu D, Cheng T, Guo H, Fernandez JA, Griffin JH, Song X, Zlokovic BV: Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. Nat Med. 2004 Dec;10(12):1379-83. Epub 2004 Oct 31. [PubMed:15516929 ]
- Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem. 2003 Jun;85(5):1299-311. [PubMed:12753088 ]
- Okuda H, Ogita K: [Protective effects of N-methyl-D-aspartate against neuronal damages]. Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Oct;22(5):153-8. [PubMed:12451685 ]
- Andre VM, Flores-Hernandez J, Cepeda C, Starling AJ, Nguyen S, Lobo MK, Vinters HV, Levine MS, Mathern GW: NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex. 2004 Jun;14(6):634-46. Epub 2004 Mar 28. [PubMed:15054078 ]
- Reyes O, Sosa I, Kuffler DP: Neuroprotection of adult human neurons against ischemia by hypothermia and alkalinization. P R Health Sci J. 2006 Mar;25(1):43-50. [PubMed:16883678 ]
- Boehning D, Snyder SH: Novel neural modulators. Annu Rev Neurosci. 2003;26:105-31. [PubMed:14527267 ]
- Tuneva EO, Bychkova ON, Boldyrev AA: Effect of NMDA on production of reactive oxygen species by human lymphocytes. Bull Exp Biol Med. 2003 Aug;136(2):159-61. [PubMed:14631498 ]
- D'Aniello S, Fisher GH, Topo E, Ferrandino G, Garcia-Fernandez J, D'Aniello A: N-methyl-D-aspartic acid (NMDA) in the nervous system of the amphioxus Branchiostoma lanceolatum. BMC Neurosci. 2007 Dec 20;8:109. doi: 10.1186/1471-2202-8-109. [PubMed:18096065 ]
- WATKINS JC: THE SYNTHESIS OF SOME ACIDIC AMINO ACIDS POSSESSING NEUROPHARMACOLOGICAL ACTIVITY. J Med Pharm Chem. 1962 Nov;91:1187-99. doi: 10.1021/jm01241a010. [PubMed:14056452 ]
- Aiyer R, Mehta N, Gungor S, Gulati A: A Systematic Review of NMDA Receptor Antagonists for Treatment of Neuropathic Pain in Clinical Practice. Clin J Pain. 2018 May;34(5):450-467. doi: 10.1097/AJP.0000000000000547. [PubMed:28877137 ]
|
---|